What podcasts say about Brennan Habetler
Every statement, with the speaker, the exact quote and the moment it was said.
What Brennan Habetler has said on podcasts
7 statements · 4 positive · 3 negative
- on ElectroMed revenuePositiveOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed revenue grew at approximately 15% annually over five years.
“revenue increasing on a very consistent basis with a compound and annual growth rate kegger at 15 over the past five years”
Open the episode · Stock Talk Podcast Episode 352Listen at 28:11
- on ElectroMed share countPositiveOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed’s share count has declined because repurchases exceeded issuance.
“the share count has actually declined as the company has bought back more shares than it's issued”
Open the episode · Stock Talk Podcast Episode 352Listen at 28:46
- on ElectroMed revenue growthNegativeOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed’s fiscal 2026 fourth-quarter revenue growth slowed meaningfully.
“It is a meaningful slowdown.”
Open the episode · Stock Talk Podcast Episode 352Listen at 29:28
- on ElectroMed fiscal 2027 growthPositiveOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed’s fiscal 2027 growth is expected to be low double-digit.
“I would expect low double-digit growth compared to the 15.3% for fiscal 2026.”
Open the episode · Stock Talk Podcast Episode 352Listen at 32:10
- on ElectroMed SmartVestNegativeOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed’s reliance on SmartVest creates material product concentration risk.
“the reliance on one product, SmartVest. This creates a concentration risk.”
Open the episode · Stock Talk Podcast Episode 352Listen at 32:32
- on ElectroMed Medicare and Medicaid reimbursementNegativeOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
Medicare and Medicaid reimbursement changes could materially affect ElectroMed.
“Medicare and Medicaid changes can meaningfully impact Electromed.”
Open the episode · Stock Talk Podcast Episode 352Listen at 32:46
- on ElectroMedPositiveOct 6, 2026· KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
ElectroMed is an appealing long-term investment.
“Overall, ElectroMed is an appealing investment.”
Open the episode · Stock Talk Podcast Episode 352Listen at 35:03
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.